Evidence map›Paper›PMID 38544526›Full record

ArticleFrontiers in cellular and infection microbiology2024

Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning.

Taís Fontoura de Almeida, Edézio Ferreira Cunha-Junior, João Luiz Mendes Wanderley, Juliana da Silva Pacheco, Lucia Helena Pinto-da-Silva, Valter Viana Andrade-Neto, Suzana Passos Chaves

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taís Fontoura de AlmeidaLaboratory of Physiopathology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
Edézio Ferreira Cunha-JuniorLaboratory of Immunoparasitology, Institute of Pharmaceutical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
João Luiz Mendes WanderleyLaboratory of Immunoparasitology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.
Juliana da Silva PachecoDrug Discovery Unit, Department of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Lucia Helena Pinto-da-SilvaInstitute of Veterinary, Department of Veterinary Microbiology and Immunology, Seropédica, RJ, Brazil.
Valter Viana Andrade-NetoSt Michael Hospital, Li ka Shing Knowledge Institute, Toronto, ON, Canada.
Suzana Passos ChavesLaboratory of Immunoparasitology, Biosciences Applied to Health Department, Institute of Medical Sciences, Multidisciplinary Center of Federal University of Rio de Janeiro, Macaé, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsLeishmaniasisDrug DiscoveryDrug RepositioningHumansImmunologic FactorsBiological ProductsImmunologic FactorschemotherapyflavonoidimmunomodulationLeishmaniananoparticlesprotozoarepositioning drugstreatment

Identifiers

PMID38544526
PMCPMC10966123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.